• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Medicines for the new coronavirus in the view of Classical Systemic Homeopathy.古典全身顺势疗法视角下的新型冠状病毒治疗药物
Complement Ther Clin Pract. 2021 Nov;45:101482. doi: 10.1016/j.ctcp.2021.101482. Epub 2021 Sep 11.
2
Interim Management of COVID-19 by Repurposed Homeopathic Medicines.用顺势疗法药物对新冠病毒病进行临时管理
Homeopathy. 2020 Aug;109(3):182-183. doi: 10.1055/s-0040-1713004. Epub 2020 Jun 9.
3
The Experience of an Italian Public Homeopathy Clinic during the COVID-19 Epidemic, March-May 2020.2020年3月至5月新冠疫情期间一家意大利公立顺势疗法诊所的经历
Homeopathy. 2020 Aug;109(3):167-168. doi: 10.1055/s-0040-1713618. Epub 2020 Jul 8.
4
The COVID-19 Pandemic: A View from New York City.《新冠疫情:来自纽约市的视角》
Homeopathy. 2020 Aug;109(3):163-166. doi: 10.1055/s-0040-1714052. Epub 2020 Jul 14.
5
Correlation of Covid-19 With Stomatognathic System With Homeopathic Proposal for Adjunct Treatment to Increase Oral and General Health.新型冠状病毒肺炎与口颌系统的相关性以及顺势疗法辅助治疗方案以增进口腔和全身健康
Altern Ther Health Med. 2020 Aug;26(S2):112-116.
6
Homeopathic Clinical Features of 18 Patients in COVID-19 Outbreaks in Hong Kong.香港新冠肺炎疫情中18例患者的顺势疗法临床特征
Homeopathy. 2020 Aug;109(3):146-162. doi: 10.1055/s-0040-1710545. Epub 2020 Jun 5.
7
Antiviral Activity of Cinchona officinalis, a Homeopathic Medicine, against COVID-19.金鸡纳树皮顺势疗法药物抗 COVID-19 的抗病毒活性。
Homeopathy. 2024 Feb;113(1):16-24. doi: 10.1055/s-0043-1770339. Epub 2023 Sep 6.
8
Antimonium Tartaricum as a Possible Homeopathic Prophylactic Remedy in the COVID-19 Epidemic.酒石酸锑钾作为 COVID-19 大流行中的一种可能的顺势疗法预防疗法。
Homeopathy. 2021 Aug;110(3):206-211. doi: 10.1055/s-0041-1725060. Epub 2021 Apr 14.
9
Homeopathic Medicines Used as Prophylaxis in Kolkata during the COVID-19 Pandemic: A Community-Based, Cluster-Randomized Trial.顺势疗法药物在 COVID-19 大流行期间在加尔各答用作预防措施:一项基于社区的、整群随机试验。
Homeopathy. 2022 May;111(2):97-104. doi: 10.1055/s-0041-1734026. Epub 2021 Oct 29.
10
Homeopathy for Covid-19 in Primary Care: A structured summary of a study protocol for a randomized controlled trial.基层医疗中顺势疗法治疗 COVID-19:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Feb 1;22(1):109. doi: 10.1186/s13063-021-05071-5.

引用本文的文献

1
Homeopathy and women's health: gynecology and homeopathy.顺势疗法与女性健康:妇科与顺势疗法
Rev Assoc Med Bras (1992). 2023 Aug 4;69(suppl 1):e2023S113. doi: 10.1590/1806-9282.2023S113. eCollection 2023.
2
Searching for the Genus Epidemicus in Chinese Patients: Findings from the Clificol COVID-19 Clinical Case Registry.中文患者中流行病种属的探索:Clificol COVID-19 临床病例登记处的发现。
Homeopathy. 2023 Feb;112(1):30-39. doi: 10.1055/s-0042-1750380. Epub 2022 Oct 2.
3
Prescription for COVID-19 by non-medical professionals during the pandemic in Colombia: a cross-sectional study.哥伦比亚疫情期间非医学专业人员开具的新冠处方:一项横断面研究
Ther Adv Drug Saf. 2022 May 24;13:20420986221101964. doi: 10.1177/20420986221101964. eCollection 2022.

本文引用的文献

1
A comprehensive review of COVID-19 characteristics.对新冠病毒特性的全面综述。
Biol Proced Online. 2020 Aug 4;22:19. doi: 10.1186/s12575-020-00128-2. eCollection 2020.
2
Protecting Frontline Health Care Workers from COVID-19 with Hydroxychloroquine Pre-exposure Prophylaxis: A structured summary of a study protocol for a randomised placebo-controlled multisite trial in Toronto, Canada.羟氯喹暴露前预防以保护一线医护人员免受 COVID-19 感染:一项在加拿大多伦多进行的随机安慰剂对照多中心试验的研究方案的结构化总结。
Trials. 2020 Jul 14;21(1):647. doi: 10.1186/s13063-020-04577-8.
3
Clinical research protocol to evaluate the effectiveness and safety of individualized homeopathic medicine in the treatment and prevention of the COVID-19 epidemic.评估个体化顺势疗法药物在治疗和预防新冠疫情中的有效性和安全性的临床研究方案。
Rev Assoc Med Bras (1992). 2020 Apr;66(4):405-406. doi: 10.1590/1806-9282.66.4.405.
4
Treatment Considerations for COVID-19: A Critical Review of the Evidence (or Lack Thereof).治疗新冠肺炎的考虑因素:对证据(或缺乏证据)的批判性回顾。
Mayo Clin Proc. 2020 Jul;95(7):1454-1466. doi: 10.1016/j.mayocp.2020.04.027. Epub 2020 Apr 30.
5
Potential pro-arrhythmic effects of pharmacotherapy against SARS-CoV-2.抗SARS-CoV-2药物治疗的潜在促心律失常作用。
Arch Cardiol Mex. 2020;90(Supl):36-40. doi: 10.24875/ACM.M20000061.
6
Hydroxychloroquine as prophylaxis or treatment for COVID-19: What does the evidence say?羟氯喹作为 COVID-19 的预防或治疗药物:证据说了什么?
Indian J Public Health. 2020 Jun;64(Supplement):S125-S127. doi: 10.4103/ijph.IJPH_496_20.
7
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.羟氯喹作为 COVID-19 暴露后预防的随机试验。
N Engl J Med. 2020 Aug 6;383(6):517-525. doi: 10.1056/NEJMoa2016638. Epub 2020 Jun 3.
8
[Hydroxychloroquine. Cardiology's viewpoint in times of coronavirus pandemic].[羟氯喹啉。冠状病毒大流行时期心脏病学的观点]
Medicina (B Aires). 2020;80(3):271-274.
9
Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19.氯喹和羟氯喹治疗 COVID-19 的疗效。
Eur Rev Med Pharmacol Sci. 2020 Apr;24(8):4539-4547. doi: 10.26355/eurrev_202004_21038.
10
COVID-19: Disease, management, treatment, and social impact.新型冠状病毒肺炎:疾病、管理、治疗和社会影响。
Sci Total Environ. 2020 Aug 1;728:138861. doi: 10.1016/j.scitotenv.2020.138861. Epub 2020 Apr 22.

古典全身顺势疗法视角下的新型冠状病毒治疗药物

Medicines for the new coronavirus in the view of Classical Systemic Homeopathy.

作者信息

Gosik Maria Solange, Mendes Maria Filomena Xavier, Werneck Dos Santos Leticia Marilia de Almeida, Barbas Danielle da Silva, Cabo Domingos José Vaz do, Strastis Hristos, Duarte Takeuti Isabella Sebusiani, Mourão Leila Cristina Dos Santos, Delavechia Maria Luiza, Cunha Marina Xavier da, Kalile Raquel Bruno, Lino Renata Rodrigues Garcia, Brunelli William, Oliveira Adriana Passos, Carillo Romeu

机构信息

Taboão da Serra Youth Psychosocial Care Center, São Paulo, SP, Brazil; Brazilian Association of Recycling and Assistance in Homeopathy, Aclimação, São Paulo, SP, Brazil.

Municipal Health Secretariat, Rio de Janeiro, RJ, Brazil; Brazilian Association of Recycling and Assistance in Homeopathy, Aclimação, São Paulo, SP, Brazil.

出版信息

Complement Ther Clin Pract. 2021 Nov;45:101482. doi: 10.1016/j.ctcp.2021.101482. Epub 2021 Sep 11.

DOI:10.1016/j.ctcp.2021.101482
PMID:34530182
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8433054/
Abstract

INTRODUCTION

According to the World Health Organization, the coronavirus disease 2019 (COVID-19) has 48.896.564 reported cases and 1.236.995 deaths worldwide on November 5, 2020. Despite great efforts, there is no treatment of COVID-19 up to nowadays. Therefore, it is essential to search for therapeutic alternatives to COVID-19, such as Integrative Medicine, especially Homeopathy, which was used with excellent results in the great epidemics.

AIM

This study aims to describe the coronavirus Pandemic from the perspective of Classical Systemic Homeopathy and to identify the homeopathic medicine (medicines genius) that has its sphere of action in most of the symptoms involved in this pandemic.

METHODS

Articles published in indexed journals and websites of medical institutions, books of homeopathic materia medica, scientific journals, and government publications were reviewed.

RESULTS

A total of 39 references were selected and enclosed 20 articles indexed on COVID-19, 08 references of systemic conditions, 11 articles indexed of homeopathy, 06 classic homeopathy books. After the study, the homeopathic medicine Cinchona officinalis (China officinalis) was proposed, according to pathogenesis (experimental pathophysiological study in humans) described in the materia medica books consulted, for the relief of symptoms. Its sphere of action in most of the symptoms involved in this pandemic. Moreover, acute homeopathic medicines were determined to act in the relief of symptoms of the various phases of the manifestations of the disease.

CONCLUSION

Data contributes to use in homeopathic interventions during the COVID-19 epidemic as a health promotion and treatment strategy that can be used as an adjunct to all sanitary and therapeutic measures recommended by health authorities.

摘要

引言

根据世界卫生组织的数据,截至2020年11月5日,全球2019冠状病毒病(COVID-19)报告病例达48896564例,死亡1236995例。尽管付出了巨大努力,但迄今为止仍没有针对COVID-19的治疗方法。因此,寻找COVID-19的治疗替代方法至关重要,例如整合医学,尤其是顺势疗法,在重大疫情中使用顺势疗法取得了出色效果。

目的

本研究旨在从古典全身顺势疗法的角度描述冠状病毒大流行,并确定在该大流行所涉及的大多数症状中具有作用范围的顺势疗法药物(药物精华)。

方法

对索引期刊、医疗机构网站上发表的文章、顺势疗法药物书籍、科学期刊和政府出版物进行了综述。

结果

共筛选出39篇参考文献,其中包括20篇关于COVID-19的索引文章、8篇全身病症参考文献、11篇顺势疗法索引文章、6本古典顺势疗法书籍。研究后,根据所查阅的药物书籍中描述的发病机制(人体实验病理生理学研究),提出使用顺势疗法药物金鸡纳(中国金鸡纳)来缓解症状。它在该大流行所涉及的大多数症状中具有作用范围。此外,确定急性顺势疗法药物可缓解疾病表现各阶段的症状。

结论

这些数据有助于在COVID-19疫情期间将顺势疗法干预作为一种健康促进和治疗策略加以应用,可作为卫生当局推荐的所有卫生和治疗措施的辅助手段。